Authors

• Helena Radbruch (ORCID: https://orcid.org/0000-0001-6941-3397)
• Peter Vajkoczy (ORCID: https://orcid.org/0000-0003-4350-392X)
• Nadja Jung
• Jan Bukatz
• Atik Baborie
• R. Ates
• Katharina Faust (ORCID: https://orcid.org/0000-0001-9969-0141)
• Philip Bischoff (ORCID: https://orcid.org/0000-0002-4442-7116)
• Nikolaj Frost (ORCID: https://orcid.org/0000-0001-7452-7129)
• David Capper (ORCID: https://orcid.org/0000-0003-1945-497X)
• Nils Ole Schmidt (ORCID: https://orcid.org/0000-0001-6910-8843)
• David Horst (ORCID: https://orcid.org/0000-0003-4755-5743)
• Julia Onken (ORCID: https://orcid.org/0000-0002-2859-4395)
• Markus J. Riemenschneider (ORCID: https://orcid.org/0000-0001-7658-1022)
• Anton Früh (ORCID: https://orcid.org/0000-0002-2982-2046)
• Martin Witzenrath
• Frank L. Heppner (ORCID: https://orcid.org/0000-0001-9816-8917)
• Martin Proescholdt
• Majd Abdulhamid Samman
• David Wasilewski
• Tommaso Araceli
• Selin Murad
• Julia Jünger
• Arend Koch

Institutions

• German Cancer Research Center (DE)
• Heidelberg University (DE)
• King Fahd Medical City (SA)
• University Hospital Regensburg (DE)
• Humboldt-Universität zu Berlin (DE)
• Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
• Freie Universität Berlin (DE)
• Charité - Universitätsmedizin Berlin (DE)

Publication Details

Journal

Journal of Neuro-Oncology

Published

2024-12-04

DOI

https://doi.org/10.1007/s11060-024-04885-y

Citations

4

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

1.68

Funders

• Charité – Universitätsmedizin Berlin
• Deutschen Konsortium für Translationale Krebsforschung
• Berlin Institute of Health